Meiji Yasuda Life Insurance’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$925K Buy
15,259
+5,380
+54% +$314K 0.03% 141
2025
Q4
$533K Buy
9,879
+3,640
+58% +$175K 0.02% 181
2025
Q3
$281K Buy
6,239
+453
+8% +$21.2K 0.01% 213
2025
Q2
$268K Buy
5,786
+506
+10% +$24.8K 0.01% 218
2025
Q1
$322K Buy
5,280
+108
+2% +$6.29K 0.01% 216
2024
Q4
$293K Sell
5,172
-1,110
-18% -$62K 0.01% 224
2024
Q3
$325K Buy
6,282
+212
+3% +$9.95K 0.01% 212
2024
Q2
$252K Sell
6,070
-46,006
-88% -$2.06M 0.01% 228
2024
Q1
$2.82M Buy
52,076
+9,557
+22% +$487K 0.06% 86
2023
Q4
$2.18M Buy
42,519
+12,489
+42% +$656K 0.05% 102
2023
Q3
$1.74M Buy
30,030
+12,071
+67% +$740K 0.05% 109
2023
Q2
$1.15M Sell
17,959
-40
-0.2% -$2.68K 0.03% 152
2023
Q1
$1.25M Sell
17,999
-7,427
-29% -$524K 0.02% 140
2022
Q4
$1.83M Buy
25,426
+790
+3% +$59.6K 0.04% 93
2022
Q3
$1.75M Sell
24,636
-1,903
-7% -$138K 0.04% 83
2022
Q2
$2.04M Buy
26,539
+10,438
+65% +$795K 0.03% 77
2022
Q1
$1.18M Buy
16,101
+862
+6% +$57.9K 0.02% 132
2021
Q4
$950K Sell
15,239
-3,186
-17% -$187K 0.02% 160
2021
Q3
$1.09M Hold
18,425
0.02% 147
2021
Q2
$1.23M Sell
18,425
-618
-3% -$40.3K 0.02% 139
2021
Q1
$1.2M Sell
19,043
-1,000
-5% -$62.2K 0.02% 134
2020
Q4
$1.24M Sell
20,043
-6,891
-26% -$424K 0.02% 132
2020
Q3
$1.62M Sell
26,934
-7,595
-22% -$457K 0.03% 112
2020
Q2
$2.03M Sell
34,529
-1,105
-3% -$66.1K 0.08% 81
2020
Q1
$1.99M Sell
35,634
-6,857
-16% -$419K 0.4% 63
2019
Q4
$2.73M Buy
42,491
+9,456
+29% +$542K 0.37% 61
2019
Q3
$1.68M Sell
33,035
-1,251
-4% -$58.8K 0.24% 110
2019
Q2
$1.55M Buy
34,286
+6,454
+23% +$301K 0.23% 112
2019
Q1
$1.33M Sell
27,832
-5,242
-16% -$261K 0.2% 126
2018
Q4
$1.72M Buy
33,074
+4,267
+15% +$229K 0.27% 93
2018
Q3
$1.79M Sell
28,807
-560
-2% -$33.2K 0.22% 121
2018
Q2
$1.63M Sell
29,367
-4,270
-13% -$231K 0.22% 120
2018
Q1
$2.13M Sell
33,637
-2,832
-8% -$182K 0.33% 69
2017
Q4
$2.23M Sell
36,469
-5,346
-13% -$334K 0.31% 74
2017
Q3
$2.67M Sell
41,815
-1,200
-3% -$70.1K 0.39% 60
2017
Q2
$2.4M Buy
43,015
+1,470
+4% +$80K 0.37% 54
2017
Q1
$2.26M Buy
41,545
+2,500
+6% +$137K 0.36% 63
2016
Q4
$2.28M Buy
39,045
+3,270
+9% +$179K 0.38% 57
2016
Q3
$1.93M Sell
35,775
-4,810
-12% -$309K 0.26% 111
2016
Q2
$2.98M Buy
40,585
+6,770
+20% +$478K 0.48% 49
2016
Q1
$2.16M Buy
33,815
+1,200
+4% +$75.7K 0.34% 77
2015
Q4
$2.24M Sell
32,615
-1,400
-4% -$92.5K 0.36% 76
2015
Q3
$2.01M Buy
34,015
+1,900
+6% +$121K 0.34% 83
2015
Q2
$2.14M Buy
32,115
+4,300
+15% +$283K 0.33% 81
2015
Q1
$1.79M Sell
27,815
-5,069
-15% -$317K 0.28% 97
2014
Q4
$1.94M Sell
32,884
-2,400
-7% -$135K 0.29% 83
2014
Q3
$1.81M Buy
35,284
+2,801
+9% +$140K 0.28% 86
2014
Q2
$1.58M Sell
32,483
-190
-0.6% -$9.36K 0.25% 99
2014
Q1
$1.7M Buy
32,673
+9,434
+41% +$502K 0.29% 79
2013
Q4
$1.24M Sell
23,239
-1,407
-6% -$71.7K 0.21% 116
2013
Q3
$1.14M Sell
24,646
-1,549
-6% -$68K 0.21% 115
2013
Q2
$1.17M Buy
+26,195
New +$1.14M 0.22% 106

Other funds holding BMY

Meiji Yasuda Life Insurance's BMY Position: Q1 2026 in Review

Meiji Yasuda Life Insurance increased its Bristol-Myers Squibb (BMY) stake by 54% in Q1 2026, buying an estimated $314K and bringing the position to 15,259 shares worth $925K. The position accounts for 0.03% of the portfolio, ranked #141.

Meiji Yasuda Life Insurance first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.98M in Q2 2016. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Meiji Yasuda Life Insurance held 15,259 shares of Bristol-Myers Squibb worth $925K as of Q1 2026.
  • Meiji Yasuda Life Insurance bought 5,380 Bristol-Myers Squibb shares in Q1 2026, an estimated $314K.
  • Bristol-Myers Squibb made up 0.03% of Meiji Yasuda Life Insurance's portfolio in Q1 2026, its #141 holding.
  • Meiji Yasuda Life Insurance first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • Meiji Yasuda Life Insurance's Bristol-Myers Squibb position peaked at $2.98M in Q2 2016.
  • 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Meiji Yasuda Life Insurance's 13F filing for Q1 2026, filed 12 May 2026.